AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-88
Results: 1-25/88
CLOPIDOGREL, ASPIRIN, AND FIRST LINE THERAPY
Authors: GENT M KUSMIEREK J
Citation: M. Gent et J. Kusmierek, CLOPIDOGREL, ASPIRIN, AND FIRST LINE THERAPY, Cerebrovascular diseases, 8(5), 1998, pp. 303-303
THE OCCURRENCE OF SUBSEQUENT MALIGNANCY IN PATIENTS PRESENTING WITH DEEP-VEIN THROMBOSIS - RESULTS FROM A HISTORICAL COHORT STUDY
Authors: RAJAN R LEVINE M GENT M HIRSH J GEERTS W SKINGLEY P JULIAN J
Citation: R. Rajan et al., THE OCCURRENCE OF SUBSEQUENT MALIGNANCY IN PATIENTS PRESENTING WITH DEEP-VEIN THROMBOSIS - RESULTS FROM A HISTORICAL COHORT STUDY, Thrombosis and haemostasis, 79(1), 1998, pp. 19-22
INTRAARTERIAL PROUROKINASE IN ISCHEMIC STROKE - RESPONSE
Authors: DELZOPPO GJ HIGASHIDA RT FURLAN AJ ROWLEY HA GENT M
Citation: Gj. Delzoppo et al., INTRAARTERIAL PROUROKINASE IN ISCHEMIC STROKE - RESPONSE, Stroke, 29(6), 1998, pp. 1255-1256
PROACT - A PHASE-II RANDOMIZED TRIAL OF RECOMBINANT PROUROKINASE BY DIRECT ARTERIAL DELIVERY IN ACUTE MIDDLE CEREBRAL-ARTERY STROKE
Authors: DELZOPPO GJ HIGASHIDA RT FURLAN AJ PESSIN MS ROWLEY HA GENT M
Citation: Gj. Delzoppo et al., PROACT - A PHASE-II RANDOMIZED TRIAL OF RECOMBINANT PROUROKINASE BY DIRECT ARTERIAL DELIVERY IN ACUTE MIDDLE CEREBRAL-ARTERY STROKE, Stroke, 29(1), 1998, pp. 4-11
THE RELATIONSHIPS AMONG DOSE, EFFECTIVENESS, AND SIDE-EFFECTS
Authors: PATRONO C COLLER B DALEN JE FUSTER V GENT M HARKER LA HIRSH J ROTH G
Citation: C. Patrono et al., THE RELATIONSHIPS AMONG DOSE, EFFECTIVENESS, AND SIDE-EFFECTS, Chest, 114(5), 1998, pp. 470-488
CANADIAN IMPLANTABLE DEFIBRILLATOR STUDY (CIDS) - EFFECTS OF ADDITIONAL ANTIARRHYTHMIC DRUG-THERAPY ON SURVIVAL
Authors: TALAJIC M CONNOLLY S DORIAN P ROY D MITCHELL LB KLEIN G SHELDON R GREEN M TANG A GENT M ROBERTS R
Citation: M. Talajic et al., CANADIAN IMPLANTABLE DEFIBRILLATOR STUDY (CIDS) - EFFECTS OF ADDITIONAL ANTIARRHYTHMIC DRUG-THERAPY ON SURVIVAL, Circulation, 98(17), 1998, pp. 469-469
SYNERGY BETWEEN AMIODARONE AND BETA-BLOCKERS AFTER MYOCARDIAL-INFARCTION
Authors: BOISSEL JP BOUTITIE F CONNOLLY SJ CAMM JA JULIAN D GENT M JANSE M DORIAN P FRANGIN G
Citation: Jp. Boissel et al., SYNERGY BETWEEN AMIODARONE AND BETA-BLOCKERS AFTER MYOCARDIAL-INFARCTION, Circulation, 98(17), 1998, pp. 470-470
RANDOMIZED COMPARISON OF MODERATE (INR-3.0-3.5) WITH LOW-INTENSITY (INR-2.0-3.5) ANTICOAGULANT-THERAPY IN PATIENTS WITH PROSTHETIC HEART-VALVES TREATED WITH ASPIRIN (100 MG DAY)/
Authors: TURPIE AGG GENT M CRUICKSHANK MK KOVACS MJ RUDDY TD BASILE F LATOUR Y LAUPACIS A HIRSH J
Citation: Agg. Turpie et al., RANDOMIZED COMPARISON OF MODERATE (INR-3.0-3.5) WITH LOW-INTENSITY (INR-2.0-3.5) ANTICOAGULANT-THERAPY IN PATIENTS WITH PROSTHETIC HEART-VALVES TREATED WITH ASPIRIN (100 MG DAY)/, Circulation, 98(17), 1998, pp. 4026-4026
ACCURACY OF SCREENING COMPRESSION ULTRASONOGRAPHY AND CLINICAL EXAMINATION FOR THE DIAGNOSIS OF DEEP-VEIN THROMBOSIS AFTER TOTAL HIP OR KNEE ARTHROPLASTY
Authors: ROBINSON KS ANDERSON DR GROSS M PETRIE D LEIGHTON D STANISH W ALEXANDER D MITCHELL W MASON W FLEMMING B FAIRHURSTVAUGHAN M GENT M
Citation: Ks. Robinson et al., ACCURACY OF SCREENING COMPRESSION ULTRASONOGRAPHY AND CLINICAL EXAMINATION FOR THE DIAGNOSIS OF DEEP-VEIN THROMBOSIS AFTER TOTAL HIP OR KNEE ARTHROPLASTY, CAN J SURG, 41(5), 1998, pp. 368
THE INCIDENCE OF SYMPTOMATIC VENOUS THROMBOEMBOLISM DURING AND AFTER PROPHYLAXIS WITH ENOXAPARIN - A MULTIINSTITUTIONAL COHORT STUDY OF PATIENTS WHO UNDERWENT HIP OR KNEE ARTHROPLASTY
Authors: LECLERC JR GENT M HIRSH J GEERTS WH GINSBERG JS
Citation: Jr. Leclerc et al., THE INCIDENCE OF SYMPTOMATIC VENOUS THROMBOEMBOLISM DURING AND AFTER PROPHYLAXIS WITH ENOXAPARIN - A MULTIINSTITUTIONAL COHORT STUDY OF PATIENTS WHO UNDERWENT HIP OR KNEE ARTHROPLASTY, Archives of internal medicine, 158(8), 1998, pp. 873-878
TICLOPIDINE AND CLOPIDOGREL IN SECONDARY STROKE PREVENTION
Authors: BOUSSER MG ROBERTS RS GENT M
Citation: Mg. Bousser et al., TICLOPIDINE AND CLOPIDOGREL IN SECONDARY STROKE PREVENTION, Cerebrovascular diseases, 7, 1997, pp. 17-23
COMPRESSION ULTRASOUND SCREENING FAILS TO REDUCE RATE OF SYMPTOMATIC VENOUS THROMBOEMBOLIC COMPLICATIONS FOLLOWING TOTAL HIP OR KNEE ARTHROPLASTY
Authors: ANDERSON DR ROBINSON KS GROSS M GENT M
Citation: Dr. Anderson et al., COMPRESSION ULTRASOUND SCREENING FAILS TO REDUCE RATE OF SYMPTOMATIC VENOUS THROMBOEMBOLIC COMPLICATIONS FOLLOWING TOTAL HIP OR KNEE ARTHROPLASTY, Thrombosis and haemostasis, 1997, pp. 2380-2380
INTERACTION BETWEEN CYCLOSPORINE-A AND NONSTEROIDAL ANTIINFLAMMATORY DRUGS
Authors: TUGWELL P LUDWIN D GENT M ROBERTS R BENSEN W GRACE E BAKER P
Citation: P. Tugwell et al., INTERACTION BETWEEN CYCLOSPORINE-A AND NONSTEROIDAL ANTIINFLAMMATORY DRUGS, Journal of rheumatology, 24(6), 1997, pp. 1122-1125
SALMON-CALCITONIN NASAL SPRAY IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS
Authors: ADACHI JD BENSEN WG BELL MJ BIANCHI FA CIVIDINO AA CRAIG GL STURTRIDGE WC SEBALDT RJ STEELE M GORDON M THEMELES E TUGWELL P ROBERTS R GENT M
Citation: Jd. Adachi et al., SALMON-CALCITONIN NASAL SPRAY IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS, British journal of rheumatology, 36(2), 1997, pp. 255-259
PAPERS FROM THE 8TH INTERNATIONAL-SYMPOSIUM ON LONG-TERM CLINICAL-TRIALS - INTRODUCTION
Authors: YUSUF S GENT M KNATTERUD G TERRIN M
Citation: S. Yusuf et al., PAPERS FROM THE 8TH INTERNATIONAL-SYMPOSIUM ON LONG-TERM CLINICAL-TRIALS - INTRODUCTION, Controlled clinical trials, 18(6), 1997, pp. 477-477
SOME ISSUES IN THE CONSTRUCTION AND USE OF CLUSTERS OF OUTCOME EVENTS- DISCUSSION
Authors: GENT M
Citation: M. Gent, SOME ISSUES IN THE CONSTRUCTION AND USE OF CLUSTERS OF OUTCOME EVENTS- DISCUSSION, Controlled clinical trials, 18(6), 1997, pp. 546-549
NORTH-AMERICAN VASOVAGAL PACEMAKER STUDY - STUDY DESIGN AND ORGANIZATION
Authors: SHELDON RS GENT M ROBERTS RS CONNOLLY SJ
Citation: Rs. Sheldon et al., NORTH-AMERICAN VASOVAGAL PACEMAKER STUDY - STUDY DESIGN AND ORGANIZATION, PACE, 20(3), 1997, pp. 844-848
EFFECT OF PROPHYLACTIC AMIODARONE ON MORTALITY AFTER ACUTE MYOCARDIAL-INFARCTION AND IN CONGESTIVE-HEART-FAILURE - METAANALYSIS OF INDIVIDUAL DATA FROM 6500 PATIENTS IN RANDOMIZED TRIALS
Authors: CONNOLLY SJ CAIRNS J GENT M ROBERTS R YUSUF S JULIAN DG CAMM AJ FRANGIN G JANSE MJ MUNOZ A SCHWARTZ PJ SIMON P ROSENBAUM MB ELIZARI MV CAGIDE A GIROTTI LA MARTINEZ JM CARBAJALES J SCAPIN O GARGUICHEVICH J HAUAD S BELZITI C SINISI A CEREMUZYNSKI L BUDAJ A KLECZAR E NARTOWICZ E SMIELAKKOROMBEL J DYDUSZYNSKI A MACIEJEWICZ J KOKOWICZ P NAVARROLOPEZ F COSIN J MARRUGAT J GUINDO J DELUNA AB PFISTERER M OSSWALD S BURCKHARDT D BURKART F HOCKINGS B GEORGE T MAHROUS F TAYLOR R HAJAR H SINGH S FLETCHER R FISHER S SINGH B DOVAL H NUL D GRANCELLI H PERRONE S BORTMAN G CURIEL R RAMOS J GAMBARTE A GENTILE A SIRENA J TIBALDI M TOPLIKAR J NICKLAS J MCKENNA W STEWART R MICKELSON J DAS S SCHORK A KRICKLER S QUAIN L MORADY F PITT B HAMER A ARKLES L JOHNS J MORRISON L ROBERTS J
Citation: Sj. Connolly et al., EFFECT OF PROPHYLACTIC AMIODARONE ON MORTALITY AFTER ACUTE MYOCARDIAL-INFARCTION AND IN CONGESTIVE-HEART-FAILURE - METAANALYSIS OF INDIVIDUAL DATA FROM 6500 PATIENTS IN RANDOMIZED TRIALS, Lancet, 350(9089), 1997, pp. 1417-1424
AMIODARONE AFTER MYOCARDIAL-INFARCTION - EMIAT AND CAMIAT TRIALS - REPLY - REPLY
Authors: CAIRNS JA CONNOLLY SJ ROBERTS R GENT M
Citation: Ja. Cairns et al., AMIODARONE AFTER MYOCARDIAL-INFARCTION - EMIAT AND CAMIAT TRIALS - REPLY - REPLY, Lancet, 349(9067), 1997, pp. 1769-1770
ASPIRIN VERSUS CLOPIDOGREL - THE WRONG QUESTION - REPLY
Authors: GENT M
Citation: M. Gent, ASPIRIN VERSUS CLOPIDOGREL - THE WRONG QUESTION - REPLY, Lancet, 349(9054), 1997, pp. 807-807
RANDOMIZED TRIAL OF OUTCOME AFTER MYOCARDIAL-INFARCTION IN PATIENTS WITH FREQUENT OR REPETITIVE VENTRICULAR PREMATURE DEPOLARIZATIONS - CAMIAT
Authors: CAIRNS JA CONNOLLY SJ ROBERTS R GENT M
Citation: Ja. Cairns et al., RANDOMIZED TRIAL OF OUTCOME AFTER MYOCARDIAL-INFARCTION IN PATIENTS WITH FREQUENT OR REPETITIVE VENTRICULAR PREMATURE DEPOLARIZATIONS - CAMIAT, Lancet, 349(9053), 1997, pp. 675-682
CAPRIE TRIAL - REPLY
Authors: GENT M HAMPTON JR ROBERTS RS VERSTRAETE M
Citation: M. Gent et al., CAPRIE TRIAL - REPLY, Lancet, 349(9048), 1997, pp. 356-356
LOW-MOLECULAR-WEIGHT HEPARIN IN THE TREATMENT OF PATIENTS WITH VENOUSTHROMBOEMBOLISM
Authors: TENCATE JW BULLER HR GENT M HIRSH J PRINS MH BAILDON R LENSING AWA ANDERSON DR VANBEEK EJR FIESINGER JN TIJSSEN JGP VANBARNEVELD A EIMERS LT GRAAFSMA YP HETTIARACHCHI R HUTTEN B REDEKOP K HALEY S LIBERALE L FINCH T WHITTAKER S WILKINSON L PRANDONI P VILLALTA S GIROLAMI B BAGATELLA P ROSSI L GIROLAMI A PIOVELLA F BARONE M BELTRAMETTI C SERAFINI S SIRAGUSA S ASCARI E KOVACS MJ MORROW B KOVACS J KUIJER PMM KOOPMAN MMW JAGT H WEITZ J KEARON C BIAGIONI L HAAS S LOSSNER F SPENGEL FA BERGER M DEMERS C POULIN J VANDERMEER J QUE GTH SMID WM ROBINSON KS BOYLE E LECLERC JR STJACQUES B FINKENBINE S GALLUS AS COHLAN D RICH C BRANDJES DPM HOEFNAGEL CA DERIJK M TURKSTRA F DESJARDINS L COTEDESJARDINS J COUTURE L RUEL M VILLENUEVE J GEERTS WH JAY RM CODE EKI TURPIE AGG JOHNSON J NGUYEN P CUSSON JR ROY S WELLS PS BORMANIS J GOUDIE D CRUICKSHANK M VONLEWINSKI M MONREAL M SAHUQUILLO JC LAFOZ E SIMONNEAU G PARENT F JAGOT J DOUKETIS JD KINNON K GINSBERG JS BRILLEDWARDS P DONOVAN D OCKELFORD PA KASSIS J BORNAIS S PLANCHON B ELKOURI D PISTORIUS MA ESCRIBANO M GARRIDO G CHESTERMAN CN CHONG BH PRITCHARD S CADE JF BYNON T STANFORD J BRIEN WM PALMER B FAIVRE R PETITEAU B MANUCCI PM MOIA M BUCCIARELLI P
Citation: Jw. Tencate et al., LOW-MOLECULAR-WEIGHT HEPARIN IN THE TREATMENT OF PATIENTS WITH VENOUSTHROMBOEMBOLISM, The New England journal of medicine, 337(10), 1997, pp. 657-662
CLOPIDOGREL - A VIEWPOINT
Authors: GENT M
Citation: M. Gent, CLOPIDOGREL - A VIEWPOINT, Drugs, 54(5), 1997, pp. 751-751
BENEFIT OF CLOPIDOGREL IN PATIENTS WITH CORONARY-DISEASE
Authors: GENT M
Citation: M. Gent, BENEFIT OF CLOPIDOGREL IN PATIENTS WITH CORONARY-DISEASE, Circulation, 96(8), 1997, pp. 2608-2608
Risultati: 1-25 | 26-50 | 51-75 | 76-88